Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study
Diabetes, Obesity and Metabolism · 2024-12 · 26 (12) · 6070-6073
DOI: 10.1111/dom.15942 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 12.09.2024. Verfasst von Genya Aharon-Hananel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Israel.
- School of Medicine, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Yovel Cohen
Zitieren
APA
Aharon-Hananel, G., Cohen, Y., & Tau, N. (2024). Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study. Diabetes, Obesity and Metabolism, 26(12), 6070-6073. https://doi.org/10.1111/dom.15942
Vancouver
Aharon-Hananel G, Cohen Y, Tau N. Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study. Diabetes, Obesity and Metabolism. 2024;26(12):6070-6073. doi:10.1111/dom.15942
BibTeX
@article{AharonHananel2024,
author = {Aharon-Hananel, Genya and Cohen, Yovel and Tau, Noam},
title = {Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {12},
pages = {6070--6073},
doi = {10.1111/dom.15942}
}
EUVIMED